Wave of clinical studies complicates drug debate

The tidal wave of clinical trial data has made it virtually impossible for physicians to keep up with the latest developments in evidence-based medicine. Proponents say that the evidence-based movement is critical to eliminating the use of dangerous therapies. Critics counter with their argument that a strict adherence to the data undermines a doctor's role in choosing the best medicine for a patient along with the whole doctor-patient relationship. But with 25,000 medical journals around the world, and more coming online, keeping up with the evidence has become a daunting task.

- here's the article on evidence based medicine from USA Today

Suggested Articles

Chi-Med has detailed plans to seek approval from the FDA later this year in part on the strength of data from Chinese phase 3 trial.

The clamor for more transparency from the leading pandemic vaccine contenders has been getting louder.

The role gives one of the driving forces behind Bristol Myers Squibb’s $74 billion takeover of Celgene the chance to help build biotechs.